annual cash & cash equivalents:
$3.30B+$74.00M(+2.29%)Summary
- As of today (May 29, 2025), TEVA annual cash & cash equivalents is $3.30 billion, with the most recent change of +$74.00 million (+2.29%) on December 31, 2024.
- During the last 3 years, TEVA annual cash & cash equivalents has risen by +$1.14 billion (+52.42%).
- TEVA annual cash & cash equivalents is now -52.49% below its all-time high of $6.95 billion, reached on December 31, 2015.
Performance
TEVA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.70B-$1.60B(-48.58%)Summary
- As of today (May 29, 2025), TEVA quarterly cash & cash equivalents is $1.70 billion, with the most recent change of -$1.60 billion (-48.58%) on March 31, 2025.
- Over the past year, TEVA quarterly cash & cash equivalents has dropped by -$1.29 billion (-43.26%).
- TEVA quarterly cash & cash equivalents is now -75.70% below its all-time high of $6.98 billion, reached on June 30, 2016.
Performance
TEVA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TEVA Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.3% | -43.3% |
3 y3 years | +52.4% | -22.0% |
5 y5 years | +67.1% | -5.9% |
TEVA Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +52.4% | -48.9% | at low |
5 y | 5-year | at high | +67.1% | -48.9% | at low |
alltime | all time | -52.5% | >+9999.0% | -75.7% | >+9999.0% |
TEVA Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.70B(-48.6%) |
Dec 2024 | $3.30B(+2.3%) | $3.30B(-0.6%) |
Sep 2024 | - | $3.32B(+47.0%) |
Jun 2024 | - | $2.26B(-24.5%) |
Mar 2024 | - | $2.99B(-7.3%) |
Dec 2023 | $3.23B(+15.2%) | $3.23B(+43.4%) |
Sep 2023 | - | $2.25B(-15.7%) |
Jun 2023 | - | $2.67B(+24.5%) |
Mar 2023 | - | $2.14B(-23.5%) |
Dec 2022 | $2.80B(+29.4%) | $2.80B(+25.9%) |
Sep 2022 | - | $2.23B(+8.1%) |
Jun 2022 | - | $2.06B(-5.4%) |
Mar 2022 | - | $2.17B(+0.5%) |
Dec 2021 | $2.17B(-0.6%) | $2.17B(+5.9%) |
Sep 2021 | - | $2.04B(-16.1%) |
Jun 2021 | - | $2.44B(+39.8%) |
Mar 2021 | - | $1.74B(-19.9%) |
Dec 2020 | $2.18B(+10.2%) | $2.18B(+19.2%) |
Sep 2020 | - | $1.83B(-23.9%) |
Jun 2020 | - | $2.40B(+33.1%) |
Mar 2020 | - | $1.80B(-8.7%) |
Dec 2019 | $1.98B(+10.8%) | $1.98B(+59.1%) |
Sep 2019 | - | $1.24B(-42.7%) |
Jun 2019 | - | $2.17B(+9.7%) |
Mar 2019 | - | $1.97B(+10.7%) |
Dec 2018 | $1.78B(+85.0%) | $1.78B(-5.0%) |
Sep 2018 | - | $1.88B(+0.8%) |
Jun 2018 | - | $1.86B(+31.2%) |
Mar 2018 | - | $1.42B(+47.2%) |
Dec 2017 | $963.00M(-2.5%) | $963.00M(+41.6%) |
Sep 2017 | - | $680.00M(+13.5%) |
Jun 2017 | - | $599.00M(-33.4%) |
Mar 2017 | - | $900.00M(-8.9%) |
Dec 2016 | $988.00M(-85.8%) | $988.00M(-36.5%) |
Sep 2016 | - | $1.56B(-77.7%) |
Jun 2016 | - | $6.98B(+17.1%) |
Mar 2016 | - | $5.96B(-14.1%) |
Dec 2015 | $6.95B(+212.0%) | $6.95B(+648.5%) |
Sep 2015 | - | $928.00M(-13.1%) |
Jun 2015 | - | $1.07B(-68.6%) |
Mar 2015 | - | $3.40B(+52.6%) |
Dec 2014 | $2.23B(+114.5%) | $2.23B(+51.1%) |
Sep 2014 | - | $1.47B(+55.2%) |
Jun 2014 | - | $949.00M(+5.3%) |
Mar 2014 | - | $901.00M(-13.2%) |
Dec 2013 | $1.04B(-63.9%) | $1.04B(-9.6%) |
Sep 2013 | - | $1.15B(-7.8%) |
Jun 2013 | - | $1.25B(-10.7%) |
Mar 2013 | - | $1.39B(-51.6%) |
Dec 2012 | $2.88B(+162.7%) | $2.88B(+101.0%) |
Sep 2012 | - | $1.43B(+20.5%) |
Jun 2012 | - | $1.19B(+11.9%) |
Mar 2012 | - | $1.06B(-3.1%) |
Dec 2011 | $1.10B(-12.2%) | $1.10B(+1.0%) |
Sep 2011 | - | $1.08B(-4.7%) |
Jun 2011 | - | $1.14B(+58.0%) |
Mar 2011 | - | $721.00M(-42.2%) |
Dec 2010 | $1.25B | $1.25B(+33.5%) |
Sep 2010 | - | $935.00M(-80.7%) |
Jun 2010 | - | $4.85B(+106.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $2.36B(+18.1%) |
Dec 2009 | $2.00B(+7.6%) | $2.00B(+24.8%) |
Sep 2009 | - | $1.60B(-9.3%) |
Jun 2009 | - | $1.76B(-25.1%) |
Mar 2009 | - | $2.35B(+26.8%) |
Dec 2008 | $1.85B(+24.6%) | $1.85B(-35.0%) |
Sep 2008 | - | $2.85B(+14.9%) |
Jun 2008 | - | $2.48B(-1.0%) |
Mar 2008 | - | $2.51B(+68.6%) |
Dec 2007 | $1.49B(+11.7%) | $1.49B(-1.3%) |
Sep 2007 | - | $1.51B(-6.8%) |
Jun 2007 | - | $1.62B(+37.6%) |
Mar 2007 | - | $1.18B(-11.7%) |
Dec 2006 | $1.33B(+4.4%) | $1.33B(+59.8%) |
Sep 2006 | - | $833.50M(-3.4%) |
Jun 2006 | - | $863.10M(-10.9%) |
Mar 2006 | - | $968.30M(-24.1%) |
Dec 2005 | $1.28B(+62.8%) | $1.28B(+81.5%) |
Sep 2005 | - | $703.10M(-15.7%) |
Jun 2005 | - | $834.30M(+18.9%) |
Mar 2005 | - | $701.60M(-10.5%) |
Dec 2004 | $784.00M(-25.8%) | $784.00M(-14.6%) |
Sep 2004 | - | $918.10M(+29.0%) |
Jun 2004 | - | $711.70M(+0.2%) |
Mar 2004 | - | $710.00M(-32.8%) |
Dec 2003 | $1.06B(+30.5%) | $1.06B(+32.1%) |
Sep 2003 | - | $800.10M(-9.0%) |
Jun 2003 | - | $879.30M(-5.4%) |
Mar 2003 | - | $929.40M(+14.8%) |
Dec 2002 | $809.90M(+5.3%) | $809.90M(+117.8%) |
Sep 2002 | - | $371.80M(-35.5%) |
Jun 2002 | - | $576.30M(-11.9%) |
Mar 2002 | - | $653.80M(-15.0%) |
Dec 2001 | $768.92M(+82.8%) | $768.92M(-4.3%) |
Sep 2001 | - | $803.30M(+139.0%) |
Jun 2001 | - | $336.09M(-4.8%) |
Mar 2001 | - | $353.06M(-16.1%) |
Dec 2000 | $420.63M(+445.0%) | $420.63M(+350.3%) |
Jun 2000 | - | $93.41M(-13.7%) |
Mar 2000 | - | $108.25M(+40.3%) |
Dec 1999 | $77.18M(+63.9%) | $77.18M(-35.9%) |
Sep 1999 | - | $120.40M(+115.4%) |
Jun 1999 | - | $55.90M(-19.9%) |
Mar 1999 | - | $69.80M(+48.2%) |
Dec 1998 | $47.10M(-7.5%) | $47.10M(-15.6%) |
Sep 1998 | - | $55.80M(-41.4%) |
Jun 1998 | - | $95.30M(+56.5%) |
Mar 1998 | - | $60.90M(+19.6%) |
Dec 1997 | $50.90M(-16.8%) | $50.90M(-16.8%) |
Dec 1996 | $61.20M(-5.7%) | $61.20M(-5.7%) |
Dec 1995 | $64.90M(+53.1%) | $64.90M(+53.1%) |
Dec 1994 | $42.40M(+6.3%) | $42.40M(+6.3%) |
Dec 1993 | $39.90M(+189.1%) | $39.90M(+189.1%) |
Dec 1992 | $13.80M(+74.7%) | $13.80M(+74.7%) |
Dec 1991 | $7.90M(-48.7%) | $7.90M(-48.7%) |
Dec 1990 | $15.40M(+234.8%) | $15.40M(+234.8%) |
Dec 1989 | $4.60M(-64.9%) | $4.60M(-64.9%) |
Dec 1988 | $13.10M(-17.6%) | $13.10M(-17.6%) |
Mar 1987 | $15.90M(-29.0%) | $15.90M(-29.0%) |
Mar 1986 | $22.40M | $22.40M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of TEVA is $3.30B
What is the all time high annual cash & cash equivalents for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash & cash equivalents is $6.95B
What is Teva Pharmaceutical Industries Limited annual cash & cash equivalents year-on-year change?
Over the past year, TEVA annual cash & cash equivalents has changed by +$74.00M (+2.29%)
What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TEVA is $1.70B
What is the all time high quarterly cash & cash equivalents for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash & cash equivalents is $6.98B
What is Teva Pharmaceutical Industries Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, TEVA quarterly cash & cash equivalents has changed by -$1.29B (-43.26%)